Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5851_Библиотеки_им_академика_М_И_Перельмана.pdf
426
24. Hawryluk GWJ, Aguilera S, Buki A, etal. A management algorithm for patients with intracranial pressure monitoring: the Seattle international severe traumatic brain injury consensus
conference (SIBICC). Intensive Care Med. 2019;45(12):1783–94. https://doi.org/10.1007/
s00134- 019- 05805- 9.
25.
Alam HB,
in trauma: management of intracranial hypertension in patients with severe traumatic
brain injuries. J Trauma Acute Care Surg. 2020;88(2):345–51. https://doi.org/10.1097/
TA.0000000000002555.
26.
orre-Healy A, Marko NF, Weil RJ.Hyperosmolar therapy for intracranial hypertension.
T
Neurocrit Care. 2012;17(1):117–30. https://doi.org/10.1007/s12028- 011- 9649- x.
27.
Bor
Arch Intern Med. 1982;142(1):63–6.
28.
Coté CJ, Greenho
istration of hypertonic solutions in man and in the rabbit. Anesthesiology. 1979;50(1):30–5.
https://doi.org/10.1097/00000542- 197901000- 00007.
29.
Fishman RA.
NEJM197510022931407.
30.
vid M, Gilboe D, Cesario T. The rebound phenomenon and hypertonic solutions.
Ja
J Neurosurg. 1964;21:1059–66. https://doi.org/10.3171/jns.1964.21.12.1059.
31.
Maioriello
tol in acute cerebral ischemia. Case report J Neurosurg. 2002;97(3):687–91. https://doi.
org/10.3171/jns.2002.97.3.0687.
32.
Anderson P
variability in the plasma and CSF levels. Eur J Clin Pharmacol. 1988;35(6):643–9. https://
doi.org/10.1007/BF00637601.
33.
Rudehill
of mannitol on hemodynamics, blood and cerebrospinal uid electrolytes, and osmolality during intracranial surgery. J Neurosurg Anesthesiol. 1993;5(1):4–12. https://doi.
org/10.1097/00008506- 199301000- 00002.
34.
James
Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir.
1977;36(3–4):189–200. https://doi.org/10.1007/BF01405391.
vussin P, Archer DP, Tyler JL, et al. Effects of rapid mannitol infusion on cerebral
35.
Ra
blood volume. A positron emission tomographic study in dogs and man. J Neurosurg.
1986;64(1):104–13. https://doi.org/10.3171/jns.1986.64.1.0104.
36.
Lin SY
mannitol infusion in patients with acute stroke. Medicine (Baltimore). 2015;94(47):e2032.
https://doi.org/10.1097/MD.0000000000002032.
37.
Better OS, Rubinstein I,
Kidney Int. 1997;52(4):886–94. https://doi.org/10.1038/ki.1997.409.
38.
Pérez-Pérez
lowing massive mannitol infusion. Am J Nephrol. 2002;22(5–6):573–5. https://doi.
org/10.1159/000065279.
39.
Dick
mulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J
Kidney Dis. 2008;51(3):491–503. https://doi.org/10.1053/j.ajkd.2007.10.044.
40.
Bentle
recognition and prevention strategies. Crit Care Med. 2010;38(6 Suppl):S169–74. https://doi.
org/10.1097/CCM.0b013e3181de0c60.
41.
Frank JI.
1995;45(7):1286–90. https://doi.org/10.1212/wnl.45.7.1286.
42.
García-Morales EJ, Cariappa R, P
neurologic-neurosurgical intensive care unit: its normal value, calculation, and relation-
Vercruysse G, Martin M, et al. Western trauma association critical decisions
ges HF, Hocks J, Kjellstrand CM.Mannitol intoxication in patients with renal failure.
w DE, Marshall BE.The hypotensive response to rapid intravenous admin-
Brain edema. N Engl J Med. 1975;293(14):706–11. https://doi.org/10.1056/
AV, Chaljub G, Nauta HJW, Lacroix M. Chemical shift imaging of manni-
, Boréus L, Gordon E, etal. Use of mannitol during neurosurgery: interpatient
A, Gordon E, Ohman G, Lindqvist C, Andersson P.Pharmacokinetics and effects
HE, Langtt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension.
, Tang SC, Tsai LK, etal. Incidence and risk factors for acute kidney injury following
Winaver JM, Knochel JP.Mannitol therapy revisited (1940–1997).
AJ, Pazos B, Sobrado J, Gonzalez L, Gándara A. Acute renal failure fol-
enmann M, Oettl T, Mihatsch MJ.Osmotic nephrosis: acute kidney injury with accu-
y ML, Corwin HL, Dasta J.Drug-induced acute kidney injury in the critically ill adult:
Large hemispheric infarction, deterioration, and intracranial pressure. Neurology.
arvin CA, Scott MG, Diringer MN. Osmole gap in
L. V. JuradoHernández and T. A. Allison
Traumatic Brain Injury
16
ship with mannitol serum concentrations. Crit Care Med. 2004;32(4):986–91. https://doi.
org/10.1097/01.ccm.0000120057.04528.60.
43. Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced
acute renal failure. Medicine (Baltimore). 1990;69(3):153–9. https://doi.
org/10.1097/00005792- 199005000- 00003.
44.
Gadallah MF
hemodialysis and postulate of mechanisms. Am J Med Sci. 1995;309(4):219–22. https://doi.
org/10.1097/00000441- 199504000- 00006.
45.
Rabeto
much mannitol is too much? Ann Pharmacother. 1993;27(1):25–8. https://doi.
org/10.1177/106002809302700105.
46.
Hays
among neurointensivists. Neurocrit Care. 2011;14(2):222–8. https://doi.org/10.1007/
s12028- 010- 9477- 4.
47.
Erstad BL.
for caution. Am J Health Syst Pharm. 2023;80(15):1032–5. https://doi.org/10.1093/ajhp/
zxad103.
48.
Holden DN, Mucksa
treating cerebral edema: a review of optimal formulation, dosing, safety, administration and
storage. Am J Health Syst Pharm. 2023;80(6):331–42. https://doi.org/10.1093/ajhp/zxac368.
49.
Perez CA, Figueroa SA.
peripheral intravenous access. J Neurosci Nurs. 2017;49(3):191–5. https://doi.org/10.1097/
JNN.0000000000000286.
50. Faiver L, Hensler D, Rush SC, Kashlan O, Williamson CA, Rajajee V.Safety and efcacy
of 23.4% sodium chloride administered via peripheral venous access for the treatment of
cerebral herniation and intracranial pressure elevation. Neurocrit Care. 2021;35(3):845–52.
https://doi.org/10.1007/s12028-
51.
Jones GM, Bode L, Riha H, Erdman MJ.
sodium chloride solution in neurocritical care patients. Am J Crit Care. 2016;26(1):37–42.
https://doi.org/10.4037/ajcc2017439.
Mesghali E, Fitter S, Bahjri K, Moussavi K.Safety of peripheral line administration of 3%
52.
hypertonic saline and mannitol in the emergency department. J Emerg Med. 2019;56(4):431–6.
https://doi.org/10.1016/j.jemermed.2018.12.046.
53.
Merrer J, De Jonghe B, Golliot F
eterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286(6):700–7.
https://doi.org/10.1001/jama.286.6.700.
54. Vedantam A, Robertson CS, Gopinath SP. Morbidity and mortality associated with hypernatremia in patients with severe traumatic brain injury. Neurosurg Focus. 2017;43(5):E2.
https://doi.org/10.3171/2017.7.FOCUS17418.
55.
Aiyag
high is too high? J Crit Care. 2006;21(2):163–72. https://doi.org/10.1016/j.jcrc.2005.10.002.
56.
Lee YI, Ahn J, Ryu JA.Clinical outcomes associated with degree of hypernatremia in neuro-
critically ill patients. J Korean Neurosurg Soc. 2023;66(1):95–104. https://doi.org/10.3340/
jkns.2022.0161.
wryluk GWJ, Editorial. Sodium values and the use of hyperosmolar therapy following
57.
Ha
traumatic brain injury. Neurosurg Focus. 2017;43(5):E3. https://doi.org/10.3171/2017.8.F
OCUS17506.
58. Nagami GT.Hyperchloremia—why and how. Nefrologia. 2016;36(4):347–53. https://doi.
org/10.1016/j.nefro.2016.04.001.
59.
Zhang Z, Xu X, F
with acute kidney injury in unselected critically ill patients. BMC Nephrol. 2013;14:235.
https://doi.org/10.1186/1471-
, Lynn M, Work J.Case report: mannitol nephrotoxicity syndrome: role of
y GM, Fredericks MR, Hostettler CF. Where the kidney is concerned, how
AN, Lazaridis C, Neyens R, Nicholas J, Gay S, Chalela JA. Osmotherapy: use
Peripheral intravenous administration of 23.4% sodium chloride solution: a plea
vage JJ, Cokley JA, etal. Hypertonic saline use in neurocritical care for
Complication rates of 3% hypertonic saline infusion through
021- 01248- 7.
Safety of continuous peripheral infusion of 3%
, etal. Complications of femoral and subclavian venous cath-
ari V, Deibert E, Diringer MN.Hypernatremia in the neurologic intensive care unit: how
an H, Li D, Deng H.Higher serum chloride concentrations are associated
2369- 14- 235.
427
428
L. V. JuradoHernández and T. A. Allison
60. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M.Association between a chlorideliberal vs chloride-restricti
critically ill adults. JAMA. 2012;308(15):1566–72. https://doi.org/10.1001/jama.2012.13356.
61.
Semler MW
adults. N Engl J Med. 2018;378(9):829–39. https://doi.org/10.1056/NEJMoa1711584.
62.
Cook
hypertonic saline. Am J Health Syst Pharm. 2020;77(19):1543–5. https://doi.org/10.1093/
ajhp/zxaa226.
63. Aegisdottir H, Cooray C, Wirdefeldt K, Piehl F, Sveinsson O.Incidence of osmotic demyelination syndrome in Sweden: a nationwide study. Acta Neurol Scand. 2019;140(5):342–9.
https://doi.org/10.1111/ane.13150.
64. Devlin JW, Skrobik Y, Gélinas C, et al. Clinical practice guidelines for the prevention
and management of pain, agitation/sedation, delirium, immobility, and sleep disruption
in adult patients in the ICU. Crit Care Med. 2018;46(9):e825–73. https://doi.org/10.1097/
CCM.0000000000003299.
65.
Rhone
effects on cerebral physiology. Neurol Res. 2001;23(2–3):237–59. https://doi.
org/10.1179/016164101101198398.
66.
Oddo
Crit Care. 2016;20(1):128. https://doi.org/10.1186/s13054- 016- 1294- 5.
67.
Shapiro HM,
sistent intracranial hypertension. J Neurosurg. 1974;40(1):90–100. https://doi.org/10.3171/
jns.1974.40.1.0090.
68.
Bricolo
J Neurosurg. 1981;55(3):397–406. https://doi.org/10.3171/jns.1981.55.3.0397.
69.
Roberts I, Sydenham E.
Syst Rev. 2012;2012(12):CD000033. https://doi.org/10.1002/14651858.CD000033.pub2.
70.
Roberts DJ, Hall RI, Kramer
for critically ill adults with severe traumatic brain injury: a systematic review of randomized controlled trials. Crit Care Med. 2011;39(12):2743–51. https://doi.org/10.1097/
CCM.0b013e318228236f.
71.
Bilotta F
brain neuroprotection: a qualitative review of randomized clinical trials. Br J Anaesth.
2013;110(Suppl 1):i113–20. https://doi.org/10.1093/bja/aet059.
72.
Eisenber
control of elevated intracranial pressure in patients with severe head injury. J Neurosurg.
1988;69(1):15–23. https://doi.org/10.3171/jns.1988.69.1.0015.
73.
Schw
of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci. 1984;11(4):434–40. https://doi.org/10.1017/
s0317167100045960.
74.
Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the
treatment of severe head injury. J Neurosurg. 1985;62(3):383–8. https://doi.org/10.3171/
jns.1985.62.3.0383.
75.
Drakulo
as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised
trial. Lancet. 1999;354(9193):1851–8. https://doi.org/10.1016/S0140-
76.
Feldman Z, Kanter MJ, Robertson CS, etal. Effect of head elevation on intracranial pressure,
cerebral perfusion pressure, and cerebral blood ow in head-injured patients. J Neurosurg.
1992;76(2):207–11. https://doi.org/10.3171/jns.1992.76.2.0207.
enning JA, Toutant SM, Saunders RL. Upright patient positioning in the manage-
77.
K
ment of intracranial hypertension. Surg Neurol. 1981;15(2):148–52. https://doi.
org/10.1016/0090-
, Self WH, Wanderer JP, etal. Balanced crystalloids versus saline in critically ill
AM, Cook TS, Rosen-Lamer A.Errors with extemporaneous compounding of buffered
y DH, Parker D. Use of sedative and analgesic agents in neurotrauma patients:
M, Crippa IA, Mehta S, etal. Optimizing sedation in patients with acute brain injury.
Wyte SR, Loeser J.Barbiturate-augmented hypothermia for reduction of per-
AP, Glick RP.Barbiturate effects on acute experimental intracranial hypertension.
, Gelb AW, Stazi E, Titi L, Paoloni FP, Rosa G. Pharmacological perioperative
g HM, Frankowski RF, Contant CF, Marshall LF, Walker MD.High-dose barbiturate
artz ML, Tator CH, Rowed DW, Reid SR, Meguro K, Andrews DF. The University
vic MB, Torres A, Bauer TT, Nicolas JM, Nogué S, Ferrer M.Supine body position
ve intravenous uid administration strategy and kidney injury in
Barbiturates for acute traumatic brain injury. Cochrane Database
AH, Robertson HL, Gallagher CN, Zygun DA. Sedation
6736(98)12251- 1.
3019(81)90037- 9.
raumatic Brain Injury
16
T
78. Ropper AH, O’Rourke D, Kennedy SK.Head position, intracranial pressure, and compliance.
Neurology. 1982;32(11):1288–91. https://doi.org/10.1212/wnl.32.11.1288.
79. Burnol L, Payen JF, Francony G, etal. Impact of head-of-bed posture on brain oxygenation in
patients with acute brain injury: a prospective cohort study. Neurocrit Care. 2021;35(3):662–8.
https://doi.org/10.1007/s12028- 021- 01240- 1.
80.
O’Grady NP
the infectious diseases society of America guidelines for evaluating new fever in adult
patients in the ICU. Crit Care Med. 2023;51(11):1570–86. https://doi.org/10.1097/
CCM.0000000000006022.
81.
Marion D
Suppl):S43–5. https://doi.org/10.1097/01.ccm.0000110731.69637.16.
82.
Li J, Jiang J, yao. Chinese Head
of acute head trauma patients. J Neurotrauma. 2012;29(1):96–100. https://doi.org/10.1089/
neu.2011.1753.
83.
Bao
sis of traumatic brain injury. PLoS One. 2014;9(3):e90956. https://doi.org/10.1371/journal.
pone.0090956.
84.
Puccio
thermia attenuates intracranial hypertension and reduces fever burden after severe traumatic
brain injury. Neurocrit Care. 2009;11(1):82–7. https://doi.org/10.1007/s12028- 009- 9213- 0.
85.
Greer DM, Funk SE, Rea
in patients with stroke and neurologic injury: a comprehensive meta-analysis. Stroke.
2008;39(11):3029–35. https://doi.org/10.1161/STROKEAHA.108.521583.
86.
Stocchetti N, Protti
oxygenation after acute brain injury. J Neurol Neurosurg Psychiatry. 2005;76(8):1135–9.
https://doi.org/10.1136/jnnp.2004.041269.
87.
Cairns CJS,
Crit Care. 2002;8(2):106–10. https://doi.org/10.1097/00075198-
88.
Choi HA, K
ture modulation: the Columbia anti-shivering protocol. Neurocrit Care. 2011;14(3):389–94.
https://doi.org/10.1007/s12028- 010- 9474- 7.
yeth BG, Jiang JY, Liu S. Behavioral protection by moderate hypothermia initiated
89.
L
after experimental traumatic brain injury. J Neurotrauma. 1993;10(1):57–64. https://doi.
org/10.1089/neu.1993.10.57.
90.
Polderman KH.
hypothermia. Crit Care Med. 2009;37(7 Suppl):S186–202. https://doi.org/10.1097/
CCM.0b013e3181aa5241.
91.
Sahuquillo J,
ence the pathophysiology of traumatic brain injury. Curr Pharm Des. 2007;13(22):2310–22.
https://doi.org/10.2174/138161207781368756.
92.
Wright S, Peralta S, Ranasinghe L.
agement for post-cardiac arrest patients. AJBSR. 2020;9(1):043.
93.
Uski J, Lamusuo S,
injury and the effect of posttraumatic epilepsy. Neurology. 2018;91(9):e878–83. https://doi.
org/10.1212/WNL.0000000000006077.
94.
Englander J, Cifu DX, Diaz-Arrastia R.
matic brain injury. Arch Phys Med Rehabil. 2014;95(6):1223–4. https://doi.org/10.1016/j.
apmr.2013.06.002.
95. Torbic H, Forni AA, Anger KE, Degrado JR, Greenwood BC.Use of antiepileptics for seizure prophylaxis after traumatic brain injury. Am J Health Syst Pharm. 2013;70(9):759–66.
https://doi.org/10.2146/ajhp120203.
96.
Laing J, Gabbe B, Chen Z, Perucca P
early posttraumatic seizures in moderate to severe traumatic brain injury. JAMA Neurol.
2022;79(4):334–41. https://doi.org/10.1001/jamaneurol.2021.5420.
, Alexander E, Alhazzani W, et al. Society of critical care medicine and
W.Controlled normothermia in neurologic intensive care. Crit Care Med. 2004;32(2
Trauma Data Bank: effect of hyperthermia on the outcome
L, Chen D, Ding L, Ling W, Xu F.Fever burden is an independent predictor for progno-
AM, Fischer MR, Jankowitz BT, Yonas H, Darby JM, Okonkwo DO.Induced normo-
ven NL, Ouzounelli M, Uman GC.Impact of fever on outcome
A, Lattuada M, etal. Impact of pyrexia on neurochemistry and cerebral
Andrews PJD.Management of hyperthermia in traumatic brain injury. Curr Opin
200204000- 00003.
o SB, Presciutti M, etal. Prevention of shivering during therapeutic tempera-
Mechanisms of action, physiological effects, and complications of
Vilalta A. Cooling the injured brain: how does moderate hypothermia inu-
A review of adverse effects of targeted temperature man-
Teperi S, Löyttyniemi E, Tenovuo O.Mortality after traumatic brain
Information/education page. Seizures and trau-
, Kwan P, O’Brien TJ. Risk factors and prognosis of
429
430
L. V. JuradoHernández and T. A. Allison
97. Pease M, Mallela AN, Elmer J, et al. Association of posttraumatic epilepsy with longterm functional outcomes in indi
2023;100(19):e1967–75. https://doi.org/10.1212/WNL.0000000000207183.
98.
Pease M, Gonzalez-Martinez J, Puccio
after severe traumatic brain injury. Ann Neurol. 2022;92(4):663–9. https://doi.org/10.1002/
ana.26443.
99. Temkin NR.Risk factors for posttraumatic seizures in adults. Epilepsia. 2003;44(s10):18–20.
https://doi.org/10.1046/j.1528- 1157.44.s10.6.x.
100.
ablon SA.Posttraumatic seizures. Arch Phys Med Rehabil. 1993;74(9):983–1001.
Y
101.
Montgomery MC, Chou JW
phenytoin concentrations: effects of albumin concentration and kidney dysfunction.
Pharmacotherapy. 2019;39(7):756–66. https://doi.org/10.1002/phar.2273.
102.
103.
104.
105. Okogbaa JI, Onor IO, Arije OA, Harris MB, Lillis RA.Phenytoin-induced purple glove syn-
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117. Ley EJ, Brown CVR, Moore EE, etal. Updated guidelines to reduce venous thromboembo-
W, Kiang TKL, Bring P, Ensom MHH. Predictive performance of the winter-Tozer
Cheng
and derivative equations for estimating free phenytoin concentration. Can J Hosp Pharm.
2016;69(4):269–79. https://doi.org/10.4212/cjhp.v69i4.1573.
Algren D
Med. 2014;174(1):167. https://doi.org/10.1001/jamainternmed.2013.11177.
Earnest MP
of seizures. Recommendations for usage. JAMA. 1983;249(6):762–5.
drome: a case report and review of the literature. Hosp Pharm. 2015;50(5):391–5. https://doi.
org/10.1310/hpj5005- 391.
Adams BD, Buckle
unstable bradydysrhythmias. J Emerg Med. 2006;30(1):75–9. https://doi.org/10.1016/j.
jemermed.2005.01.034.
Thomson
ment of its clinical and economic outcomes. Core Evid. 2005;1(1):65–75.
Swadron SP, Rudis MI, Azimian K, Beringer P, Fort D, Orlinsky M.A comparison of phenytoin-
loading techniques in the emer
https://doi.org/10.1111/j.1553-
Newman JW, Blunck JR, Fields RK, Croom JE.Fosphenytoin-induced purple glove syn-
drome: a case report. Clin Neurol Neurosurg. 2017;160:50–3. https://doi.org/10.1016/j.
clineuro.2017.06.006.
Ohman K, Kram B, Schultheis J, et
seizure prophylaxis following traumatic brain injury. Neurocrit Care. 2023;38(2):345–55.
https://doi.org/10.1007/s12028-
Haller JT
tam. Epilepsia. 2021;62(8):1865–70. https://doi.org/10.1111/epi.16961.
Mor
tiracetam. Neurocrit Care. 2020;32(1):131–4. https://doi.org/10.1007/s12028-
Theleng
effects on introduction of levetiracetam versus oxcarbazepine for epilepsy. Epilepsy Res.
2019;150:58–65. https://doi.org/10.1016/j.eplepsyres.2019.01.004.
W
Healthcare. 2013;22(3):198–202. https://doi.org/10.1177/201010581302200307.
Geerts
embolism after major trauma. N Engl J Med. 1994;331(24):1601–6. https://doi.org/10.1056/
NEJM199412153312401.
Denson K, Mor
patients with traumatic brain injury. Am J Surg. 2007;193(3):380–3; discussion 383–384.
https://doi.org/10.1016/j.amjsurg.2006.12.004.
lism in trauma patients: a Western trauma association critical decisions algorithm. J Trauma
Acute Care Surg. 2020;89(5):971–81. https://doi.org/10.1097/TA.0000000000002830.
A, Christian MR.Phenytoin toxicity unlikely to result in arrhythmias. JAMA Intern
, Marx JA, Drury LR.Complications of intravenous phenytoin for acute treatment
y NH, Kim JY, Tipps LB. Fosphenytoin may cause hemodynamically
A.Fosphenytoin for the treatment of status epilepticus: an evidence-based assess-
, Bonnin S, Radosevich J.Rapid administration of undiluted intravenous levetirace-
gan O, Medenwald B. Safety and tolerability of rapid administration undiluted leve-
ana A, Shukla G, Srivastava A, etal. Cognitive, behavioural and sleep-related adverse
u MF, Lim WH. Phenytoin: a guide to therapeutic drug monitoring. Proc Singapore
WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thrombo-
gan D, Cunningham R, et al. Incidence of venous thromboembolism in
viduals with severe traumatic brain injury. Neurology.
A, et al. Risk factors and incidence of epilepsy
, McPharlin TO, Baird GS, Anderson GD.Predicting unbound
gency department. Acad Emerg Med. 2004;11(3):244–52.
2712.2004.tb02204.x.
al. Evaluation of levetiracetam dosing strategies for
022- 01599- 9.
019- 00708- 5.
Traumatic Brain Injury
16
118. Vandiver JW, Ritz LI, Lalama JT.Chemical prophylaxis to prevent venous thromboembolism
in morbid obesity: literature review and dosing recommendations. J Thromb Thrombolysis.
2016;41(3):475–81. https://doi.org/10.1007/s11239- 015- 1231- 5.
119.
Greeneld LJ, Proctor MC, Rodriguez JL, Luchette F
J. Posttrauma thromboembolism prophylaxis. J Trauma. 1997;42(1):100–3. https://doi.
org/10.1097/00005373- 199701000- 00017.
120.
Rogers FB, Shackford SR, Horst MA, et
ment for patients with trauma: the trauma embolic scoring system. J Trauma Acute Care
Surg. 2012;73(2):511–5. https://doi.org/10.1097/ta.0b013e3182588b54.
121. Walker PF, Schobel S, Caruso JD, et al. Trauma embolic scoring system in military
trauma: a sensitive predictor of venous thromboembolism. Trauma Surg Acute Care Open.
2019;4(1):e000367. https://doi.org/10.1136/tsaco- 2019- 000367.
122.
Phelan HA.
injury: a critical literature review. J Neurotrauma. 2012;29(10):1821–8. https://doi.
org/10.1089/neu.2012.2459.
123.
Lozier
a critical review of the literature. Neurosurgery. 2002;51(1):170–81; discussion 181–182.
https://doi.org/10.1097/00006123- 200207000- 00024.
124.
Hoefnagel
related to external ventricular drainage. Acta Neurochir. 2008;150(3):209–14; discussion
214. https://doi.org/10.1007/s00701- 007- 1458- 9.
125.
Edw
antibiotic-impregnated shunts and external ventricular drains in hydrocephalus. J Neurosurg.
2015;122(1):139–47. https://doi.org/10.3171/2014.9.JNS131277.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
yne CH, Hassan M, Zabramski JM. The efcacy and cost of prophy-
Alle
lactic and periprocedural antibiotics in patients with external ventricular
drains. Neurosurgery. 2000;47(5):1124–7.; discussion 1127-1129. https://doi.
org/10.1097/00006123-
Edw
controlled
Lancet. 2005;365(9475):1957–9. https://doi.org/10.1016/S0140-
Fried
drains: an evidence-based consensus statement: a statement for healthcare professionals from
the neurocritical care society. Neurocrit Care. 2016;24(1):61–81. https://doi.org/10.1007/
s12028- 015- 0224- 8.
Ratilal B, Costa J, Sampaio C.
ventricular shunts: a systematic review. J Neurosurg Pediatr. 2008;1(1):48–56. https://doi.
org/10.3171/PED-
Bratzler D
bial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283. https://doi.
org/10.2146/ajhp120568.
Quenot JP, Thiery N, Barbar S.When should stress ulcer prophylaxis be used in the ICU?
Curr Opin Crit Care. 2009;15(2):139–43. https://doi.org/10.1097/MCC.0b013e32832978e0.
Moody
North Am. 1976;56(6):1469–78. https://doi.org/10.1016/s0039-
Kemp WJ, Bashir A, Dababneh H, Cohen-Gadol AA.Cushing’s ulcer: further reections.
Asian J Neurosurg. 2015;10(2):87–94. https://doi.org/10.4103/1793- 5482.154976.
Helmy A, Vizcaychipi M, Gupta AK. Traumatic brain injury: intensive care management.
Br J Anaesth. 2007;99(1):32–42. https://doi.org/10.1093/bja/aem139.
Mohebbi
Med Cent). 2009;22(4):373–6. https://doi.org/10.1080/08998280.2009.11928562.
Cook D, Guyatt G.
patients. N Engl J Med. 2018;378(26):2506–16. https://doi.org/10.1056/NEJMra1605507.
Pharmacologic venous thromboembolism prophylaxis after traumatic brain
AP, Sciacca RR, Romagnoli MF, Connolly ES.Ventriculostomy-related infections:
D, Dammers R, Ter Laak-Poort MP, Avezaat CJJ.Risk factors for infections
ards NC, Engelhart L, Casamento EMH, McGirt MJ. Cost-consequence analysis of
200011000- 00020.
ards P, Arango M, Balica L, etal. Final results of MRC CRASH, a randomised placebo-
trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months.
HI, Nathan BR, Rowe AS, etal. The insertion and management of external ventricular
Antibiotic prophylaxis for surgical introduction of intracranial
08/01/048.
W, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicro-
FG, Cheung LY.Stress ulcers: their pathogenesis, diagnosis, and treatment. Surg Clin
L, Hesch K.Stress ulcer prophylaxis in the intensive care unit. Proc (Bayl Univ
Prophylaxis against upper gastrointestinal bleeding in hospitalized
al. Determining venous thromboembolic risk assess-
A, Cipolle MD, Cho
6736(05)66552- X.
6109(16)41099- 6.
431
432
137. Barletta JF, Bruno JJ, Buckley MS, Cook DJ. Stress ulcer prophylaxis. Crit Care Med.
2016;44(7):1395–405. https://doi.org/10.1097/CCM.0000000000001872.
138. Cook DJ, Grifth LE, Walter SD, etal. The attributable mortality and length of intensive care
unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care.
2001;5(6):368–75. https://doi.org/10.1186/cc1071.
139.
Tsiotos GG, Mullan
diac surgery. Am J Surg. 1994;167(6):553–7. https://doi.org/10.1016/0002- 9610(94)90096- 5.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.
151.
152.
153.
154.
Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP commission on therapeu-
ASHP
tics and approved by the ASHP board of directors on November 14, 1998. Am J Health Syst
Pharm. 1999;56(4):347–79. https://doi.org/10.1093/ajhp/56.4.347.
Spirt MJ.
2004;26(2):197–213. https://doi.org/10.1016/s0149- 2918(04)90019- 7.
Cook DJ, Fuller HD, Guyatt GH, et
ill patients. Canadian critical care trials group. N Engl J Med. 1994;330(6):377–81. https://
doi.org/10.1056/NEJM199402103300601.
Rhodes
lines for management of sepsis and septic shock: 2016. Crit Care Med. 2017;45(3):486–552.
https://doi.org/10.1097/CCM.0000000000002255.
Schunack
Pharmacol Ther. 1987;1(Suppl 1):493S–503S. https://doi.org/10.1111/j.1365- 2036.1987.
tb00658.x.
CRASH-3 trial collaborators. Ef
sive events and other morbidities in patients with acute traumatic brain injury (CRASH-3):
a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713–23. https://doi.
org/10.1016/S0140- 6736(19)32233- 0.
Lier H, Mae
of landmark studies and a critical reappraisal of its use over the last decade. Anesth Analg.
2019;129(6):1574–84. https://doi.org/10.1213/ANE.0000000000004389.
CRASH-2
vascular occlusive events, and blood transfusion in trauma patients with signicant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23–32.
https://doi.org/10.1016/S0140- 6736(10)60835- 5.
Kim C, P
pedic surgical hemorrhage: current evidence. J Blood Med. 2015;6:239–44. https://doi.
org/10.2147/JBM.S61915.
Oertel M, K
tors and consequences of the evolving injury. J Neurosurg. 2002;96(1):109–16. https://doi.
org/10.3171/jns.2002.96.1.0109.
Narayan RK, Maas
rhage: a prospective observational study. J Neurotrauma. 2008;25(6):629–39. https://doi.
org/10.1089/neu.2007.0385.
Zhang J, He M, Song Y, Xu J.Prognostic role of D-dimer level upon admission in patients with
traumatic brain injury. Medicine (Baltimore). 2018;97(31):e11774. https://doi.org/10.1097/
MD.0000000000011774.
Hone
J Clin Neurosci. 2022;99:1–4. https://doi.org/10.1016/j.jocn.2022.02.029.
Taccone FS, Citerio G, Stocchetti N.Is tranexamic acid going to CRASH the management
of traumatic brain injury? Intensive Care Med. 2020;46(6):1261–3. https://doi.org/10.1007/
s00134- 019- 05879- 5.
Lawati KA, Sharif S, Maqbali SA, etal. Efcacy and safety of tranexamic acid in acute trau-
matic brain injury: a systematic review and meta-analysis of randomized-controlled trials.
Intensive Care Med. 2021;47(1):14–27. https://doi.org/10.1007/s00134-
Stress-related mucosal disease: risk factors and prophylactic therapy. Clin Ther.
A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guide-
ark SSH, Davey JR.Tranexamic acid for the prevention and management of ortho-
ybul S, Ho KM, Rosenfeld JV. The role of tranexamic acid in traumatic brain injury.
y CJ, Zietlow S, van Heerden JA.Abdominal complications following car-
al. Risk factors for gastrointestinal bleeding in critically
W. What are the differences between the H2-receptor antagonists? Aliment
fects of tranexamic acid on death, disability, vascular occlu-
gele M, Shander A.Tranexamic acid for acute hemorrhage: a narrative review
Trial Collaborators, Shakur H, Roberts I, etal. Effects of tranexamic acid on death,
elly DF, McArthur D, etal. Progressive hemorrhage after head trauma: predic-
AIR, Servadei F, et al. Progression of traumatic intracerebral hemor-
L. V. JuradoHernández and T. A. Allison
020- 06279- w.
Traumatic Brain Injury
16
433
155. Jones PA, Andrews PJ, Midgley S, etal. Measuring the burden of secondary insults in headinjured patients during intensi
156. Rovlias A, Kotsou S.The inuence of hyperglycemia on neurological outcome in patients
with severe head injury. Neurosurgery. 2000;46(2):335–42; discussion 342–343. https://doi.
org/10.1097/00006123- 200002000- 00015.
157.
Cochran
pediatric traumatic brain injury. J Trauma. 2003;55(6):1035–8. https://doi.org/10.1097/01.
TA.0000031175.96507.48.
158.
De Salles
and cerebral blood ow in severely head-injured patients. Neurosurgery. 1987;21(1):45–50.
https://doi.org/10.1227/00006123- 198707000- 00009.
159.
Rosner MJ, Ne
response. J Neurosurg. 1984;61(1):76–86. https://doi.org/10.3171/jns.1984.61.1.0076.
160. Welsh FA, Ginsberg MD, Rieder W, Budd WW.Deleterious effect of glucose pretreatment
on recovery from diffuse cerebral ischemia in the cat. II Regional metabolite levels. Stroke.
1980;11(4):355–63. https://doi.org/10.1161/01.str.11.4.355.
161. Oddo M, Schmidt JM, Mayer SA, Chioléro RL. Glucose control after severe brain
injury. Curr Opin Clin Nutr Metab Care. 2008;11(2):134–9. https://doi.org/10.1097/
MCO.0b013e3282f37b43.
162.
Zygun D
brain injury. Neurosurgery. 2004;55(4):877–81.; discussion 882. https://doi.org/10.1227/01.
neu.0000137658.14906.e4.
163.
Abi-Saab
between brain extracellular uid and plasma in conscious human subjects: effects of hyperglycemia and hypoglycemia. J Cereb Blood Flow Metab. 2002;22(3):271–9. https://doi.
org/10.1097/00004647- 200203000- 00004.
Parkin M, Hopwood S, Jones DA, etal. Dynamic changes in brain glucose and lactate in
164.
pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line
microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab.
2005;25(3):402–13. https://doi.org/10.1038/sj.jcbfm.9600051.
165.
Vespa P, McArthur DL, Stein N, et al. Tight glycemic control increases metabolic distress
in traumatic brain injury: a randomized controlled within-subjects trial. Crit Care Med.
2012;40(6):1923–9. https://doi.org/10.1097/CCM.0b013e31824e0fcc.
166. Vespa P, Boonyaputthikul R, McArthur DL, etal. Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio
after traumatic brain injury. Crit Care Med. 2006;34(3):850–6. https://doi.org/10.1097/01.
CCM.0000201875.12245.6F.
167.
V
with poor outcome 6 months after human traumatic brain injury despite a lack of increased
lactate: a microdialysis study. J Cereb Blood Flow Metab. 2003;23(7):865–77. https://doi.
org/10.1097/01.WCB.0000076701.45782.EF.
168.
Ryken TC, McDermott M, Robinson PD, et al. The role of steroids in the management
of brain metastases: a systematic review and evidence-based clinical practice guideline.
J Neuro-Oncol. 2010;96(1):103–14. https://doi.org/10.1007/s11060-
169.
Alderson P
of randomised controlled trials. BMJ. 1997;314(7098):1855–9. https://doi.org/10.1136/
bmj.314.7098.1855.
170. Samuel S, Allison TA, Lee K, Choi HA. Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nurs. 2016;48(2):82–9. https://doi.
org/10.1097/JNN.0000000000000207.
171.
Bagule
after acquired brain injury: consensus on conceptual denition, nomenclature, and diagnostic
criteria. J Neurotrauma. 2014;31(17):1515–20. https://doi.org/10.1089/neu.2013.3301.
A, Scaife ER, Hansen KW, Downey EC. Hyperglycemia and outcomes from
AA, Muizelaar JP, Young HF.Hyperglycemia, cerebrospinal uid lactic acidosis,
wsome HH, Becker DP. Mechanical brain injury: the sympathoadrenal
A, Steiner LA, Johnston AJ, etal. Hyperglycemia and brain tissue pH after traumatic
WM, Maggs DG, Jones T, etal. Striking differences in glucose and lactate levels
espa PM, McArthur D, O’Phelan K, etal. Persistently low extracellular glucose correlates
, Roberts I. Corticosteroids in acute traumatic brain injury: systematic review
y IJ, Perkes IE, Fernandez-Ortega JF, et al. Paroxysmal sympathetic hyperactivity
ve care. J Neurosurg Anesthesiol. 1994;6(1):4–14.
009- 0057- 4.
434
172. Choi HA, Jeon SB, Samuel S, Allison T, Lee K.Paroxysmal sympathetic hyperactivity after
acute brain injury. Curr Neurol Neurosci Rep. 2013;13(8):370. https://doi.org/10.1007/
s11910- 013- 0370- 3.
173.
Fernandez-Orte
Quesada-Garcia G, Baguley IJ.Paroxysmal sympathetic hyperactivity after traumatic brain
injury: clinical and prognostic implications. J Neurotrauma. 2012;29(7):1364–70. https://doi.
org/10.1089/neu.2011.2033.
174.
Bagule
traumatic brain injury: evidence of persisting overresponsiveness to afferent stimuli. Am J
Phys Med Rehabil. 2009;88(8):615–22. https://doi.org/10.1097/PHM.0b013e3181aeab96.
175.
Sharma R, Shultz SR, Robinson MJ, et
complex interplay between the immune and neurological systems. Brain Behav Immun.
2019;79:63–74. https://doi.org/10.1016/j.bbi.2019.04.034.
176.
Alhar IM, Charyk Ste
associated factors in pediatric severe traumatic brain injury. J Neurotrauma. 2014;31(5):452–8.
https://doi.org/10.1089/neu.2013.2904.
177. Vincent JL, Bihari DJ, Suter PM, etal. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care
(EPIC) Study. EPIC International Advisory Committee. JAMA. 1995;274(8):639–44.
178.
Dziedzic
injured patients. Crit Care. 2004;8(4):266–70.
incent JL. Nosocomial infections in adult intensive-care units. Lancet.
179.
V
2003;361(9374):2068–77. https://doi.org/10.1016/S0140- 6736(03)13644- 6.
180. Kourbeti IS, Vakis AF, Papadakis JA, etal. Infections in traumatic brain injury patients. Clin
Microbiol Infect. 2012;18(4):359–64. https://doi.org/10.1111/j.1469- 0691.2011.03625.x.
181.
Hazeldine J, Naumann DN,
of multiple organ dysfunction syndrome following traumatic injury: a prospective cohort
study. PLoS Med. 2017;14(7):e1002338. https://doi.org/10.1371/journal.pmed.1002338.
olach B, Sazbon L, Gavrieli R, Broda A, Schlesinger M.Early immunological defects
182.
W
in comatose patients after acute brain injury. J Neurosurg. 2001;94(5):706–11. https://doi.
org/10.3171/jns.2001.94.5.0706.
183.
Chan KH, Mann KS.
Neurosurgery. 1988;23(4):436–8. https://doi.org/10.1227/00006123-
184.
Omar MA, Mohd Haspani MS.
tion at Hospital Kuala Lumpur: an observational study. Malays J Med Sci. 2010;17(3):48–54.
Tunkel AR, Hasbun R, Bhimraj A, etal. 2017 Infectious Diseases Society of America’s clini-
185.
cal practice guidelines for healthcare-associated ventriculitis and meningitis. Clin Infect Dis.
2017;64(6):e34–65. https://doi.org/10.1093/cid/ciw861.
186.
Deshayes S, Coquerel
antibiotics: a literature review. Drug Saf. 2017;40(12):1171–98. https://doi.org/10.1007/
s40264-
187.
Bhattacharyya S, Darby RR, Raibagkar P, Gonzalez Castro LN, Berkowitz AL.Antibiotic-
associated encephalopath
WNL.0000000000002455.
188.
Sugimoto M, Uchida I, Mashimo
blockade in convulsions induced by cephalosporins. Neuropharmacology. 2003;45(3):304–14.
https://doi.org/10.1016/s0028-
189.
Fujimoto M, Munakata M, Akaike N.Dual mechanisms of GABAA response inhibition by
beta-lactam antibiotics in the pyramidal neurones of the rat cerebral cortex. Br J Pharmacol.
1995;116(7):3014–20. https://doi.org/10.1111/j.1476-
190.
Sugimoto M, Fukami S, Kayakiri H, et
elis have different mechanisms and sites of action at GABA(A) receptors. Br J Pharmacol.
2002;135(2):427–32. https://doi.org/10.1038/sj.bjp.0704496.
ga JF, Prieto-Palomino MA, Garcia-Caballero M, Galeas-Lopez JL,
y IJ, Heriseanu RE, Nott MT, Chapman J, Sandanam J.Dysautonomia after severe
wart T, Al Helali I, Daoud H, Fraser DD.Infection rates, fevers, and
T, Slowik A, Szczudlik A.Nosocomial infections and immunity: lesson from brain-
Toman E, etal. Prehospital immune responses and development
Prolonged therapeutic external ventricular drainage: a prospective study.
The risk factors of external ventricular drainage-related infec-
A, Verdon R. Neurological adverse effects attributable to β-lactam
017- 0578- 2.
y. Neurology. 2016;86(10):963–71. https://doi.org/10.1212/
T, etal. Evidence for the involvement of GABA(a) receptor
3908(03)00188- 6.
al. The beta-lactam antibiotics, penicillin-G and cefos-
L. V. JuradoHernández and T. A. Allison
al. Infections after a traumatic brain injury: the
https://doi.org/10.1186/cc2828.
198810000- 00005.
5381.1995.tb15957.x.
raumatic Brain Injury
16
T
191. Barreto EF, Webb AJ, Pais GM, Rule AD, Jannetto PJ, Scheetz MH.Setting the beta-lactam
therapeutic range for critically ill patients: is there a oor or even a ceiling? Crit Care Explor.
2021;3(6):e0446. https://doi.org/10.1097/CCE.0000000000000446.
192. Payne LE, Gagnon DJ, Riker RR, etal. Cefepime-induced neurotoxicity: a systematic review.
Crit Care. 2017;21(1):276. https://doi.org/10.1186/s13054- 017- 1856- 1.
193.
Ojha N, Riaz S, Eranki
Cureus. 2020;12(8):e9911. https://doi.org/10.7759/cureus.9911.
194.
Balderia PG, Chandorkar
renal function does not completely prevent neurotoxicity in a patient with kidney transplant.
J Patient Saf. 2018;14(2):e33–4. https://doi.org/10.1097/PTS.0000000000000225.
195.
196.
197.
198.
199.
200.
201.
202.
203.
204.
205.
206.
207.
208.
209.
210.
yjnikov D, Luedke MW.Cefepime-induced encephalopathy and nonconvulsive status
Tchap
epilepticus: dispelling an articial dichotomy. Neurohospitalist. 2019;9(2):100–4. https://doi.
org/10.1177/1941874418803225.
Maan G, K
J Antimicrob Chemother. 2022;77(11):2908–21. https://doi.org/10.1093/jac/dkac271.
Cho
to bedside. Eur J Clin Microbiol Infect Dis. 2005;24(10):649–53. https://doi.org/10.1007/
s10096- 005- 0021- y.
Meier
org/10.1177/0885066615625194.
Chatzipanteli K,
mia and hyperthermia on the inammatory response after uid percussion brain injury: biochemical and immunocytochemical studies. J Cereb Blood Flow Metab. 2000;20(3):531–42.
https://doi.org/10.1097/00004647- 200003000- 00012.
Childers MK, Rupright J, Smith D
bilitation. Brain Inj. 1994;8(4):335–43. https://doi.org/10.3109/02699059409150984.
Me
propranolol. Arch Phys Med Rehabil. 1994;75(7):816–8.
Segatore M.Fever after traumatic brain injury. J Neurosci Nurs. 1992;24(2):104–9. https://
doi.org/10.1097/01376517-
Cunha BA, Digamon-Beltran M, Gobbo PN.Implications of fever in the critical care setting.
Heart Lung. 1984;13(5):460–5.
Powers JH, Scheld WM.Fever in neurologic diseases. Infect Dis Clin N Am. 1996;10(1):45–66.
https://doi.org/10.1016/s0891-
Thompson HJ,
ing traumatic brain injury: a critical evaluation. Neurobiol Dis. 2003;12(3):163–73. https://
doi.org/10.1016/s0969- 9961(02)00030- x.
Kang SH, Kim MJ, Shin IY
hyperthermia in a patient with mixed autonomic hyperactivity after neurosurgery: a case
report. J Korean Med Sci. 2012;27(8):965–8. https://doi.org/10.3346/jkms.2012.27.8.965.
u KW, Huang YH, Lin CL, Hong CZ, Chou LW.Effectively managing intractable central
Y
hyperthermia in a stroke patient by bromocriptine: a case report. Neuropsychiatr Dis Treat.
2013;9:605–8. https://doi.org/10.2147/NDT.S44547.
Gar
treated with propranolol: a case report. Neurol India. 2019;67(4):1097–9. https://doi.
org/10.4103/0028- 3886.266258.
Huang
longed central hyperthermia in a patient with basilar artery occlusion. Acta Neurol Taiwanica.
2009;18(2):118–22.
Lee HC, Kim JM, Lim JK, Jo
for patient with pontine hemorrhage. Ann Rehabil Med. 2014;38(2):269–72. https://doi.
org/10.5535/arm.2014.38.2.269.
eitoku K, Kimura N, etal. Cefepime-induced neurotoxicity: systematic review.
w KM, Hui AC, Szeto CC.Neurotoxicity induced by beta-lactam antibiotics: from bench
K, Lee K. Neurogenic Fever. J Intensive Care Med. 2017;32(2):124–9. https://doi.
ythaler JM, Stinson AM.Fever of central origin in traumatic brain injury controlled with
Tkacs NC, Saatman KE, Raghupathi R, McIntosh TK.Hyperthermia follow-
g M, Garg K, Singh PK, et al. Neurogenic fever in severe traumatic brain injury
YS, Hsiao MC, Lee M, Huang YC, Lee JD.Baclofen successfully abolished pro-
A.Cefepime neurotoxicity in a patient with acute tubular necrosis.
A, Kim Y, Patnaik S, Sloan J, Newman GC.Dosing cefepime for
Alonso OF, Kraydieh S, Dietrich WD.Importance of posttraumatic hypother-
W.Post-traumatic hyperthermia in acute brain injury reha-
199204000- 00010.
5520(05)70285- 3.
, Park DW, Sohn JW, Yoon YK. Bromocriptine for control of
YS, Kim SK. Central hyperthermia treated with baclofen
435